Can a diabetes drug help hearts heal better after a heart attack?
NCT ID NCT07469943
First seen Mar 18, 2026 · Last updated Jun 22, 2026 · Updated 11 times
Summary
This study looks at whether empagliflozin, a medicine used for diabetes, can help blood vessels and heart muscle recover after a heart attack. About 80 people who had a severe heart attack will either receive empagliflozin or standard care. Researchers will measure artery stiffness, blood vessel health, and heart function over 12 months to see if the drug makes a difference.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Attikon University Hospital, 2nd Department of Cardiology, National and Kapodistrina University of Athens
RECRUITINGAthens, Rimini1/Haidari, 12462, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
empagliflozin (a diabetes pill that also helps the heart)
What this could lead to
If it works, this could show that empagliflozin helps blood vessels and the heart recover better after a heart attack, potentially reducing future heart problems.
What could go wrong
This is a small, early-stage study with only 80 people, so results may not apply to everyone. It is not designed to prove that empagliflozin prevents death or major events.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.